Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex ...
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic treatment TA1159 3 June 2026 3 June 2026 Durvalumab with chemotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results